Back to Treatments

Treatment

Pasireotide

1
Conditions
5
Trials
500
Participants
55%
Average Safety

Condition Evidence

Cushing's Syndrome

5 trials · 500 participants

25% effectiveness · 55% safety
Pasireotide | DFDA